Eli Lilly, Others Urge 6th Circ. To Toss Darvocet Appeal

Law360, Los Angeles (November 13, 2013, 6:58 PM EST) -- Eli Lilly & Co. and other drugmakers on Tuesday urged the Sixth Circuit to deny an appeal by plaintiffs seeking to hold them liable for injuries allegedly tied to generic versions of the painkillers Darvocet and Darvon, saying brand-name manufacturers have no legal duty to generics consumers.

In an opposition brief, Eli Lilly, Xanodyne Pharmaceuticals Inc., AAIPharma Inc. and NeoSan Pharmaceuticals Inc. told the appellate court it should affirm a Kentucky district court's rulings granting their motions to dismiss the plaintiffs' claims. The companies, which are among...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.